U.S. Communications Stock News

NasdaqGS:PCVX
NasdaqGS:PCVXBiotechs

Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New Financing - Has The Bull Case Changed?

In February 2026, Vaxcyte reported a full-year 2025 net loss of US$766.63 million and higher loss per share, while also raising roughly US$408.10 million through an at-the-market follow-on equity offering and filing additional shelf capacity linked to employee stock plans. Alongside these financing moves, the company highlighted unprecedented Phase 2 results for its VAX-31 pneumococcal vaccine, rapid progression into multiple Phase 3 trials, and completion of a large-scale manufacturing...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

A Look At Collegium Pharmaceutical (COLL) Valuation After Mixed Q4 2025 Results And Updated 2026 Guidance

Collegium Pharmaceutical (COLL) shares came under pressure after its Q4 and full year 2025 report, where earnings and revenue missed some analyst estimates, while management reaffirmed and slightly lifted 2026 guidance. See our latest analysis for Collegium Pharmaceutical. The Q4 miss has come with a reset in expectations, with the 1 day share price return of a 5.77% decline at US$41.67 extending a 30 day share price return of a 9.26% decline, even though the 1 year total shareholder return...
NYSE:XPOF
NYSE:XPOFHospitality

Assessing Xponential Fitness (XPOF) Valuation After Weak Earnings And Lower 2026 Revenue Guidance

Xponential Fitness (XPOF) is back in focus after reporting fourth quarter and full year 2025 results, along with 2026 revenue guidance that points to a lower range than the prior year. See our latest analysis for Xponential Fitness. The earnings release and lower 2026 revenue guidance have coincided with sharp share price weakness, with a 1 day share price return of 47.08% decline and a 1 year total shareholder return of 67.75% decline. This points to fading momentum and a reassessment of...
NYSE:VMC
NYSE:VMCBasic Materials

Is Vulcan Materials (VMC) Fully Priced After Strong Multi Year Share Price Gains

If you are wondering whether Vulcan Materials is a fair deal at around US$310 per share, it helps to step back and look at what the current price actually reflects. The stock last closed at US$310.00, with returns of 1.5% over 7 days, 3.1% over 30 days, 5.9% year to date, 26.3% over 1 year, 73.4% over 3 years and 92.3% over 5 years, which may shape how investors are thinking about its potential and its risks today. Recent coverage has focused on Vulcan Materials as a key supplier of...
NYSE:MDU
NYSE:MDUGas Utilities

Will Steady Dividends And A US$3.10 Billion Plan Shift MDU Resources Group's (MDU) Narrative

MDU Resources Group’s board recently declared a quarterly dividend of US$0.14 per share, unchanged from the prior quarter, payable on April 1, 2026 to shareholders of record on March 12, 2026, while continuing to target a long-term payout ratio of 60% to 70% of earnings. Alongside reaffirmed earnings guidance and a multi-year US$3.10 billion capital plan as a pure-play regulated utility and pipeline operator, the full exit of activist investor Corvex Management highlights an evolving...
NYSE:AD
NYSE:ADWireless Telecom

How Array’s Tower Pivot And 2026 Revenue Guide At Array Digital Infrastructure (AD) Has Changed Its Investment Story

In February 2026, Array Digital Infrastructure reported fourth-quarter 2025 revenue of US$60.33 million and net income of US$37.48 million, while issuing 2026 revenue guidance of US$200 million to US$215 million as it pivots toward tower and site rental income after selling regional wireless operations and most spectrum licenses. This shift is reshaping the company into a largely tower-focused business, with earnings now more closely tied to long-term lease agreements with major carriers...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Assessing Mirum Pharmaceuticals (MIRM) Valuation After Recent Share Price Volatility

Mirum Pharmaceuticals stock snapshot after recent performance shifts Mirum Pharmaceuticals (MIRM) has had mixed share-price moves recently, with a small 1 day gain, a 12% decline over the past week, a 10% drop over the past month, and a 32% gain across the past 3 months. Against that backdrop, investors are weighing Mirum’s current US$92.29 share price, its recent return profile over the past year and beyond, and how that lines up with the company’s rare disease portfolio and financial...
NYSE:LB
NYSE:LBReal Estate

LandBridge (LB) Is Up 8.7% After Dividend Hike And New Buyback Plan - What's Changed

In late February 2026, LandBridge Company LLC reported past fourth-quarter revenue of US$56.78 million and net income of US$8.06 million, alongside full-year 2025 revenue of US$199.09 million and net income of US$30.13 million, while also announcing a 20% dividend increase and a new US$50 million share repurchase program. This combination of strong earnings growth, a higher cash dividend, and a sizable buyback authorization underscores management’s confidence in LandBridge’s capital-light...
NYSE:PLNT
NYSE:PLNTHospitality

Why Planet Fitness (PLNT) Is Down 9.4% After Tempered 2026 Guidance Despite Strong 2025 Results

In February 2026, Planet Fitness reported higher Q4 and full-year 2025 revenue and earnings, alongside guidance for 2026 calling for approximately 9% revenue growth. At the same time, the company’s moderated growth outlook and ongoing legal investigations contrasted with continued international expansion, including new franchise-backed clubs in northern Mexico. We’ll now examine how Planet Fitness’s tempered 2026 guidance, despite solid 2025 results, reshapes the company’s longer-term...
NYSE:BK
NYSE:BKCapital Markets

The Bull Case For Bank of New York Mellon (BK) Could Change Following New Series M Preferred Offering

On February 26, 2026, Bank of New York Mellon Corporation priced and completed a US$500,000,000 underwritten public offering of 500,000 Series M Noncumulative Perpetual Preferred Stock depositary shares at US$1,000 each, featuring callable, non-cumulative, variable-rate terms. The planned use of proceeds for general corporate purposes, including potential redemptions of existing Series F and Series H preferred stock, signals a meaningful reshaping of BNY’s capital structure and future...
NasdaqGS:CATY
NasdaqGS:CATYBanks

Cathay General Bancorp (CATY) Is Down 7.1% After Commercial Real Estate Credit Concerns Intensify

In recent days, Cathay General Bancorp has come under pressure as investors reacted to rising credit risk concerns amid hotter-than-expected inflation data and growing worries over regional banks’ exposure to commercial real estate. What makes this episode especially important is that it coincides with Cathay General’s flat sales and declining earnings per share, sharpening questions about its profitability and growth profile. We’ll now examine how heightened credit risk concerns,...
NYSE:SLG
NYSE:SLGOffice REITs

Should SL Green’s Manhattan Leasing Surge and Portfolio Shuffle Require Action From SLG Investors?

SL Green Realty recently reported past leasing gains in Manhattan, signing 56 office leases covering 0.8 million square feet and completing major portfolio moves, including the US$730,000,000 acquisition of Park Avenue Tower and a 49% joint venture sale in 100 Park Avenue, alongside higher average rental rates. An interesting takeaway is how this combination of stronger leasing, higher rents, and active portfolio reshaping is helping offset the earnings pressure created by rising interest...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

Viridian Therapeutics (VRDN) Balances Rising Losses With Veligrotug Milestones and New Employee Stock Shelf Registration

In late February 2026, Viridian Therapeutics reported fourth-quarter and full-year 2025 results showing modest revenue but a larger net loss alongside a new US$16.33 million shelf registration for employee stock offerings. At the same time, the company’s thyroid eye disease program advanced with veligrotug under FDA Priority Review and an EMA filing submitted, reinforcing its focus on late-stage assets despite higher losses. With these regulatory milestones for veligrotug in place, we’ll now...
NYSE:VTOL
NYSE:VTOLEnergy Services

A Look At Bristow Group (VTOL) Valuation After Earnings, 2026 Outlook, Refinancing And New Dividend

Earnings, guidance and capital returns in focus Bristow Group (VTOL) just paired its fourth quarter and full year 2025 results with 2026 guidance, a fresh quarterly dividend and details on a recent US$500 million refinancing at a lower coupon. The company reported Q4 2025 sales of US$377.26 million and net income of US$18.42 million, while affirming 2026 revenue expectations in a US$1.58 billion to US$1.69 billion range and maintaining its new US$0.125 quarterly cash dividend. See our latest...
NYSE:KNX
NYSE:KNXTransportation

A Look At Knight-Swift (KNX) Valuation After Earnings Miss And CFO Insider Selling

Knight-Swift Transportation Holdings (KNX) is back in focus after its fourth-quarter 2025 adjusted earnings per share of US$0.31 came in below analyst expectations, along with fresh insider selling by the company’s CFO. See our latest analysis for Knight-Swift Transportation Holdings. The recent earnings miss and CFO share sale come against a backdrop of strong recent momentum. A 30 day share price return of 14.19% and a 1 year total shareholder return of 26.67% suggest sentiment has improved...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

Will Manhattan Associates' (MANH) CFO Succession Cement Stability Or Signal Deeper Leadership Priorities?

Manhattan Associates has announced that long-serving CFO and Executive Vice President Dennis Story will retire from his roles on March 31, 2026, with veteran finance executive Linda Pinne stepping in as Chief Financial Officer, Chief Accounting Officer, and Treasurer while Story remains an advisor to the CEO through year-end 2026. This carefully staged handover, elevating a 20-year company insider who already oversees accounting and treasury, signals an emphasis on continuity in financial...
NYSE:CRC
NYSE:CRCOil and Gas

Will CRC’s Expanded ‘Grade A’ Methane Certification Redefine Its Low-Carbon Positioning in California?

In late February 2026, California Resources Corporation received its third ‘Grade A’ MiQ methane certification covering most of its San Joaquin Valley production in Fresno and Kern Counties, underscoring independently verified low-methane operations across the majority of its portfolio. This expanded certification could enhance CRC’s positioning in California’s Low Carbon Fuel Standard market, where lower-methane barrels may command a pricing premium and support its broader decarbonization...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Masimo (MASI) Valuation Check After Sharp Near‑Term Rebound And Modest Undervaluation Narrative

Why Masimo is on investor watchlists right now Masimo (MASI) has recently drawn fresh attention after a strong month in the stock, with returns over the past 3 months also standing out against a weaker 1 year total return. See our latest analysis for Masimo. The recent 27.69% 1 month share price return and 21.75% 3 month share price return, against a 1 year total shareholder return decline of 7.11%, suggests short term momentum has picked up while longer term holders are still under water at...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Zoom (ZM) Is Down 18.1% After Mixed Earnings and New AI Narrative - What's Changed

In late February 2026, Zoom Communications reported fourth-quarter revenue of about US$1.25 billion and net income of US$674.08 million, capping a full year with sales of US$4.87 billion and net income of US$1.90 billion, alongside new guidance for fiscal 2027 and completion of a US$2.70 billion share buyback program. Beyond its core operations, Zoom highlighted growing traction in AI-powered products and the potential value of its early-stage investment in Anthropic, which some commentators...
NYSE:LAD
NYSE:LADSpecialty Retail

How Board Expansion And JPMorgan’s Caution At Lithia Motors (LAD) Has Changed Its Investment Story

In February 2026, Lithia Motors’ board amended its bylaws to remove the upper limit on board size and set the director count at 10 for the 2026 annual shareholder meeting. Around the same time, JPMorgan shifted to a more cautious stance on Lithia Motors, highlighting execution visibility, cost control challenges, and higher balance sheet leverage despite an otherwise constructive industry backdrop. We’ll now examine how JPMorgan’s concerns about execution and cost control may affect Lithia...
NYSE:AGM
NYSE:AGMDiversified Financial

Federal Agricultural Mortgage (AGM) Is Up 5.5% After Dividend Hike Despite Softer Q4 Earnings - Has The Bull Case Changed?

In February 2026, Federal Agricultural Mortgage Corporation reported fourth-quarter 2025 net income of US$47.92 million, down from US$56.51 million a year earlier, while full-year net income was broadly flat at US$207.42 million, and its board approved higher dividends on both common and preferred shares. Beyond the headline earnings softness, Farmer Mac’s fifteenth consecutive annual increase in its common dividend, alongside growth in infrastructure finance such as broadband and renewable...
NYSE:MANU
NYSE:MANUEntertainment

Did Cost-Cut-Driven Q2 Profit and Reaffirmed Guidance Just Shift Manchester United's (MANU) Investment Narrative?

Manchester United plc has reported fiscal second-quarter 2026 results, with sales of £190.31 million and a net income of £4.18 million, marking a return to profit despite lower revenue than the same period a year ago. The earnings improvement stems largely from cost and headcount reductions that turned a prior-period loss into a profit, while management reiterated full-year revenue guidance of £640 million to £660 million. We’ll now look at how this cost-driven profitability turnaround,...
NYSE:ONTO
NYSE:ONTOSemiconductor

Assessing Onto Innovation (ONTO) Valuation After Strong Multi Year Returns And Premium P/E Multiple

Stock performance snapshot and recent context Onto Innovation (ONTO) has drawn attention after a period of strong multi year total returns and a recent share price of $215.89, prompting investors to reassess how its current valuation lines up with its fundamentals. See our latest analysis for Onto Innovation. While Onto Innovation’s share price has eased slightly in the very short term, with a 1 day share price return of a 0.91% decline, the 90 day share price return of 46.86% and 1 year...
NYSE:RXO
NYSE:RXOTransportation

RXO’s New Middle Mile Network Might Change The Case For Investing In RXO (RXO)

On February 25, 2026, RXO, Inc. launched its Middle Mile Solutions service, offering a single “dock-to-door” logistics network that links first-, middle-, and last-mile transportation with value-added services such as warehousing, kitting, assembly, and reverse logistics, all managed through its RXO Connect platform for end-to-end visibility. This move expands RXO beyond pure brokerage into an integrated, tech-enabled supply chain offering that could deepen customer relationships and expand...